L. Mandinov

Targeting Inflammation in Atherosclerosis: Mechanistic Rationale, Clinical Trials, and Regulatory Considerations

This narrative review examines the evolving understanding of atherosclerosis, which has shifted from a predominantly lipid-centric model to a chronic inflammatory disease, and highlights the liver as a central hub linking inflammation and thrombosis through complement and coagulation pathways.